CD4 cells count as a prognostic marker in HIV patients with comparative analysis of various studies in Asia Pacific region

• Main Authors: Puneeta Vohra, Sharayu Nimonkar, Vikram Belkhode, Suraj Potdar, Rishabh Bhanot, Izna, Rahul V C. Tiwari
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2020-01-01
• Series: Journal of Family Medicine and Primary Care
• Subjects: antiretroviral therapy; candidiasis; orofacial manifestations; systemic manifestations; tuberculosis
• Online Access: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=5;spage=2431;epage=2436;aulast=Vohra

Purpose: To evaluate the correlation between CD4+ cells count with orofacial and systemic manifestations in newly diagnosed HIV seropositive patients and comparison of results with the previous studies. Materials and Methods: Hundred (100; 57 males and 43 females) newly diagnosed HIV seropositive patients, before starting antiretroviral therapy (ART) were included in the study. These patients were clustered according to CD4+ cells count into three groups: 0–200 cells/mm3, 201–499 cells/mm3, and more than 500 cells/mm3. Orofacial and systemic manifestations of these patients were recorded and correlated with CD4 cells count values. Results: There was no significant correlation found between CD4+ cells count values of males and females using independent t-test. Chi-square test showed significant correlation between the systemic manifestations and CD4+ cells count categories. Tuberculosis was found to be the most common systemic manifestation in both the genders. In addition, a significant correlation was between the CD4+ cells count and orofacial manifestations, where oral candidiasis was found to be the most common manifestation in both the genders. Conclusion: The prevalence of systemic and orofacial manifestations increases with decrease in the CD4+ cells count of HIV seropositive patients. Hence, it can be used as diagnostic and prognostic marker for immune suppression in HIV positive patients.